These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 30013957

  • 1. Percutaneous Radiofrequency Ablation of Small (1-2 cm) Hepatocellular Carcinomas Inconspicuous on B-Mode Ultrasonographic Imaging: Usefulness of Combined Fusion Imaging with MRI and Contrast-Enhanced Ultrasonography.
    Lee MW, Lim HK, Rhim H, Cha DI, Kang TW, Song KD, Min JH, Gwak GY, Kim S, Lu DSK.
    Can J Gastroenterol Hepatol; 2018; 2018():7926923. PubMed ID: 30013957
    [Abstract] [Full Text] [Related]

  • 2. Contrast-enhanced ultrasonography-CT/MRI fusion guidance for percutaneous ablation of inconspicuous, small liver tumors: improving feasibility and therapeutic outcome.
    Lee Y, Yoon JH, Han S, Joo I, Lee JM.
    Cancer Imaging; 2024 Jan 03; 24(1):4. PubMed ID: 38172949
    [Abstract] [Full Text] [Related]

  • 3. Percutaneous US/MRI Fusion-guided Radiofrequency Ablation for Recurrent Subcentimeter Hepatocellular Carcinoma: Technical Feasibility and Therapeutic Outcomes.
    Song KD, Lee MW, Rhim H, Kang TW, Cha DI, Sinn DH, Lim HK.
    Radiology; 2018 Sep 03; 288(3):878-886. PubMed ID: 29916771
    [Abstract] [Full Text] [Related]

  • 4. Contrast-enhanced ultrasound-guided radiofrequency ablation in inconspicuous hepatocellular carcinoma on B-mode ultrasound.
    Kim EJ, Kim YS, Shin SK, Kwon OS, Choi DJ, Kim JH.
    Turk J Gastroenterol; 2017 Nov 03; 28(6):446-452. PubMed ID: 29086712
    [Abstract] [Full Text] [Related]

  • 5. Radiofrequency ablation of very-early-stage hepatocellular carcinoma inconspicuous on fusion imaging with B-mode US: value of fusion imaging with contrast-enhanced US.
    Min JH, Lim HK, Lim S, Kang TW, Song KD, Choi SY, Rhim H, Lee MW.
    Clin Mol Hepatol; 2014 Mar 03; 20(1):61-70. PubMed ID: 24757660
    [Abstract] [Full Text] [Related]

  • 6. Pretreatment evaluation with contrast-enhanced ultrasonography for percutaneous radiofrequency ablation of hepatocellular carcinomas with poor conspicuity on conventional ultrasonography.
    Kim AY, Lee MW, Rhim H, Cha DI, Choi D, Kim YS, Lim HK, Cho SW.
    Korean J Radiol; 2013 Mar 03; 14(5):754-63. PubMed ID: 24043968
    [Abstract] [Full Text] [Related]

  • 7. Fusion imaging with contrast-enhanced ultrasonography for evaluating the early therapeutic efficacy of radiofrequency ablation for small hypervascular hepatocellular carcinomas with iso-echoic or unclear margins on conventional ultrasonography.
    Nishigori S, Numata K, Irie K, Fukuda H, Chuma M, Maeda S.
    J Med Ultrason (2001); 2018 Jul 03; 45(3):405-415. PubMed ID: 29362966
    [Abstract] [Full Text] [Related]

  • 8. Combination guidance of contrast-enhanced US and fusion imaging in radiofrequency ablation for hepatocellular carcinoma with poor conspicuity on contrast-enhanced US/fusion imaging.
    Minami T, Minami Y, Chishina H, Arizumi T, Takita M, Kitai S, Yada N, Inoue T, Hagiwara S, Ueshima K, Nishida N, Kudo M.
    Oncology; 2014 Jul 03; 87 Suppl 1():55-62. PubMed ID: 25427734
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Percutaneous ultrasonography-guided radiofrequency ablation of hepatocellular carcinomas: usefulness of image fusion with three-dimensional ultrasonography.
    Park HJ, Lee MW, Rhim H, Cha DI, Kang TW, Lim S, Song KD, Lim HK.
    Clin Radiol; 2015 Apr 03; 70(4):387-94. PubMed ID: 25582889
    [Abstract] [Full Text] [Related]

  • 11. 3D fusion is superior to 2D point-to-point contrast-enhanced US to evaluate the ablative margin after RFA for hepatocellular carcinoma.
    Long H, Zhou X, Zhang X, Ye J, Huang T, Cong L, Xie X, Huang G.
    Eur Radiol; 2024 Feb 03; 34(2):1247-1257. PubMed ID: 37572191
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Thermal ablation with fusion imaging guidance of hepatocellular carcinoma without conspicuity on conventional or contrast-enhanced US: surrounding anatomical landmarks matter.
    Calandri M, Ruggeri V, Carucci P, Mirabella S, Veltri A, Fonio P, Gazzera C.
    Radiol Med; 2019 Oct 03; 124(10):1043-1048. PubMed ID: 31270723
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Radiofrequency ablation for hepatocellular carcinoma: utility of conventional ultrasound and contrast-enhanced ultrasound in guiding and assessing early therapeutic response and short-term follow-up results.
    Du J, Li HL, Zhai B, Chang S, Li FH.
    Ultrasound Med Biol; 2015 Sep 03; 41(9):2400-11. PubMed ID: 26055968
    [Abstract] [Full Text] [Related]

  • 17. A Comparative Study of SonoVue and Sonazoid for Contrast-Enhanced Ultrasound CT/MRI Fusion Guidance During Radiofrequency Ablation of Poorly Visualized Hepatic Malignancies: A Prospective Intra-Individual Analysis.
    Kim H, Kim JH, Lee JM.
    Ultrasound Med Biol; 2024 Dec 03; 50(12):1879-1884. PubMed ID: 39306481
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Value of contrast-enhanced sonography of small hepatocellular carcinoma with sonazoid prior to radiofrequency ablation.
    Lee SJ, Won HJ, Kim KW, Shin YM, Kim PN.
    J Clin Ultrasound; 2017 Sep 03; 45(7):383-390. PubMed ID: 28271531
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.